Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Optic Neuromyelitis Spectrum Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT04101058
What this trial is testing

Treatment Response Among Chinese Neuromyelitis Optica Spectrum Disorders

Who this might be right for
Neuromyelitis Optica Spectrum Disorders
Third Affiliated Hospital, Sun Yat-Sen University 200
Very early researchNot Yet RecruitingNCT07392528
What this trial is testing

Universal Chimeric Antigen Receptor T-Cell （UCAR T-cell） Therapy Targeting CD19/ BCMA（QT-019C） in Patients With r/ r Neurological Autoimmune Diseases

Who this might be right for
Neuromyelitis Optica Spectrum DisordersMultiple SclerosisMyasthenia Gravis
Tianjin Huanhu Hospital 15
Early research (Phase 1)WithdrawnNCT06869278
What this trial is testing

LCAR-AIO CAR-T Cells for Treating Relapsed/Refractory Neurological Autoimmune Diseases

Who this might be right for
Multiple Sclerosis (MS)Neuromyelitis Optica Spectrum Disease (NMOSD)Anti-Myelin Oligodendrocyte Glycoprotein-IgG Associated Disorders (MOGAD)+1 more
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Large-scale testing (Phase 3)Study completedNCT03002038
What this trial is testing

Comparison of Clinical Effects of Azathioprine and Rituximab NMO-SD Patients

Who this might be right for
Neuromyelitis Optica Spectrum Disorder
Isfahan University of Medical Sciences 86
Testing effectiveness (Phase 2)Active Not RecruitingNCT06044350
What this trial is testing

A Clinical Trial of BAT4406F Injection in Patients With Neuromyelitis Optica Spectrum Disorders

Who this might be right for
Optic Neuromyelitis Spectrum Disease
Bio-Thera Solutions 162
Not applicableLooking for participantsNCT06829524
What this trial is testing

HANDLE-a Real World Study on Satralizumab in NMOSD

Who this might be right for
Neuromyelitis Optica Spectrum Disorders (NMOSD)
Huashan Hospital 100
Not applicableStudy completedNCT05871658
What this trial is testing

Efficacy of Electroacupuncture in NMOSD Patients With Pain: Study Protocol

Who this might be right for
Neuromyelitis Optica Spectrum DisordersPain
Yuanqi Zhao,MD 20
Post-approval studies (Phase 4)Not Yet RecruitingNCT07818356
What this trial is testing

Comparative Study of Two Vaccination Schedules for the Subunit Herpes Zoster Vaccine in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disease Patients Treated With Anti-CD20 Therapy: an Open-label Randomised Controlled Trial

Who this might be right for
VaccineVaricella-zoster VirusMultiple Sclerosis+1 more
University Hospital, Toulouse 160
Not applicableLooking for participantsNCT05909761
What this trial is testing

Observational Safety Study in Women With Neuromyelitis Optica Spectrum Disorder (NMOSD) Exposed to UPLIZNA® During Pregnancy

Who this might be right for
Neuromyelitis Optica Spectrum DisorderPregnancy Related
Amgen 60
Post-approval studies (Phase 4)UnknownNCT02021825
What this trial is testing

Efficacy and Safety of Mitoxantrone in Patients With Refractory Neuromyelitis Optica and Spectrum Disorders

Who this might be right for
Neuromyelitis OpticaNeuromyelitis Optica Spectrum Disorders
Xuanwu Hospital, Beijing 50
Not applicableUnknownNCT05414487
What this trial is testing

Effects of Ofatumumab Treatment on Immune Cells and Meningeal Lymphatic Drainage in Patients With Demyelinating Diseases

Who this might be right for
Multiple SclerosisNeuromyelitis Optica Spectrum DisorderDemyelinating Diseases of the Central Nervous System
Tianjin Medical University General Hospital 34
Not applicableNot Yet RecruitingNCT05415579
What this trial is testing

Demyelinating Diseases of the Central Nervous System Registry for Patients With Traditional Chinese Medicine (DATE-TCM)

Who this might be right for
Demyelinating Diseases of the Central Nervous System (DDC)
Dongzhimen Hospital, Beijing 2,000
Not applicableWithdrawnNCT04131673
What this trial is testing

MS and NMOSD in African-Americans

Who this might be right for
Multiple SclerosisNeuromyelitis Optica
Jagannadha R Avasarala
Large-scale testing (Phase 3)Looking for participantsNCT07420296
What this trial is testing

Modified Zipper Therapy for AQP4-IgG Positive Neuromyelitis Optica Spectrum Disorder

Who this might be right for
Neuromyelitis Optica Spectrum Disorders (NMOSD)
Tianjin Medical University General Hospital 198
Not applicableUnknownNCT02889965
What this trial is testing

The French Multiple Sclerosis Registry

Who this might be right for
Multiple SclerosisNeuromyelitis Optica Spectrum Disorders
Hospices Civils de Lyon 54,000
Large-scale testing (Phase 3)Ended earlyNCT04155424
What this trial is testing

The Safety and Activity of Eculizumab in Pediatric Participants With Relapsing Neuromyelitis Optica Spectrum Disorder

Who this might be right for
Neuromyelitis OpticaNeuromyelitis Optica Spectrum Disorder
Alexion Pharmaceuticals, Inc. 5
Not applicableNot Yet RecruitingNCT07182409
What this trial is testing

Efficacy and Safety of Monoclonal Antibody in Acute Phase of Neuromyelitis Optica Spectrum Disorder

Who this might be right for
NMOSD
First Affiliated Hospital of Chongqing Medical University 40
Not applicableActive Not RecruitingNCT06906692
What this trial is testing

Meningococcal Vaccination in Patients on Complement Inhibitors

Who this might be right for
Myasthenia Gravis GeneralisedVaccinationComplement System+1 more
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 35
Not applicableLooking for participantsNCT06280755
What this trial is testing

Clinical Impact Through AI-assisted MS Care - A Retrospective Multi-center Observational Study.

Who this might be right for
Multiple SclerosisNMO Spectrum DisorderMyelin Oligodendrocyte Glycoprotein Antibody-associated Disease+2 more
icometrix 7,000
Not applicableEnrolling By InvitationNCT04886492
What this trial is testing

CorEvitas SPHERES (Synergy of Prospective Health & Experimental Research for Emerging Solutions) Registry for Neuromyelitis Optica Spectrum Disorder (NMOSD)

Who this might be right for
Neuromyelitis Optica Spectrum Disorder
CorEvitas 800
Next Page